Benefits of nuchal translucency measurement prior to 11-14 weeks' gestation
- PMID: 39093308
- DOI: 10.1002/uog.27715
Benefits of nuchal translucency measurement prior to 11-14 weeks' gestation
Comment in
-
Adverse pregnancy outcome in fetuses with early increased nuchal translucency: prospective cohort study.Ultrasound Obstet Gynecol. 2024 Aug;64(2):164-172. doi: 10.1002/uog.27623. Ultrasound Obstet Gynecol. 2024. PMID: 38411313
References
-
- Zhou Y, Wang Y, Addai FP, et al. Analysis of cell‐free fetal DNA in 16,843 pregnant women from a single center in China using targeted sequencing approach. Placenta. 2022;122:18‐22.
-
- Michos G, Sotiriadis A, Paraskevaidis E, et al. Is nuchal translucency measurement feasible in early pregnancy? Hippokratia. 2021;25(4):151‐155.
-
- Bet BB, Lugthart MA, Linskens IH, van Maarle MC, van Leeuwen E, Pajkrt E. Adverse pregnancy outcome in fetuses with early increased nuchal translucency: prospective cohort study. Ultrasound Obstet Gynecol. 2024;64(2):164‐172.
-
- Mellis R, Eberhardt RY, Hamilton SJ, et al. Fetal exome sequencing for isolated increased nuchal translucency: should we be doing it? BJOG. 2022;129(1):52‐61.
-
- Chen CP. Prenatal diagnosis of euploid increased nuchal translucency on fetal ultrasound (I): noonan syndrome: prenatal diagnosis and genetic testing. J Med Ultrasound. 2022;30(4):257‐260.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources